More Americans Stop Smoking, May be Attributed to E-Cigarettes

More Americans Stop Smoking, May be Attributed to E-Cigarettes

More Americans Stop Smoking, May be Attributed to E-Cigarettes

Vaping also increases a wannabe-quitter's chance of success, with eight percent successfully abstaining from cigarettes for at least three months compared to five per cent of traditional smokers, the research adds.

The study, which was the largest of its sort, said that around 65 percent of the vapers attempt to quit smoking, in comparison to the 40 percent of smokers who do not use e-cigarettes.

"Use of e-cigarettes was associated both with a higher quit rate for individuals as well as at the population level; driving an increase in the overall number of people quitting", said Shu-Hong Zhu, study author and UC San Diego professor of Family Medicine and Public Health and director of the Center for Research and Intervention in Tobacco Control, in a statement. "Our usual [US Food and Drug Administration (FDA)] process does not apply, as the product's been on the market already for many years".

E-cigarettes have appeared in the U.S.in 2007 and have been promoted as a less risky alternative to regular cigarettes.

This translates to about 350,000 more smokers kicking the habit.

Zhu said that their findings provided strong evidence that e-cigarettes have helped to boost rates of smoking cessation. "You tax people, they use less of the product".

The rate of people quitting smoking in the US has remained steady at about 4.5 % for years. And while we're seeing smoking rates fall rapidly across all ages, the steepest decline has been amongst younger adults.

The data was collected via the The US Current Population Survey-Tobacco Use Supplement (CPS-TUS), which is a tobacco survey distributed together with the the Current Population Survey by the US Census Bureau.

Among the 2014 survey respondents, 22,548 were current smokers and 2,136 were recent quitters.

The AHA said it is reasonable for physicians to support a patient's use of an e-cigarette to stop smoking if they have failed approved therapies and would like to try this approach. The percentage who stopped smoking for at least three months also rose, from 4.5 percent to 5.6 percent.

The study was based on a survey conducted in 2014-15. Between 2014 and 2015, the quitting rate was of 5.6 percent, while between 2010 and 2011 it was of 4.5 percent. This does not contain tar, or other chemicals usually found in cigarettes. "The logic is made a little bit easier in this case because cigarettes are so bad", said Zhu. The new study, published in BMJ medical journal, stands in contrast to previous studies suggesting that using e-cigarettes actually makes it harder to quit.

Mr Hajek said: 'It's absolutely clear that e-cigarettes help smokers replace cigarettes'.

"In light of the evidence, policy makers in countries contemplating a more restrictive approach to the regulation of e-cigarettes should pause to consider if pursuing such a course of action is the right thing to do for population health", Bullen wrote.

The public perception of e-cigarettes is that they represent a more attractive option than smoking tobacco, because they are believed to be safer than a conventional cigarette as well as less grubby. But it did find that e-cigs do have a role in helping people quit.

Nicotine patches, gum and medications are known to aid smoking cessation, but there's no consensus on whether vaping devices can help anti-smoking efforts. "We do know that in this country the approach that has been taken by governmental agencies and nongovernmental public health organizations is to focus, nearly with tunnel vision, on the potential risks to kids".

But while the risks of e-cigarettes are still somewhat unclear, some public health experts say the results are promising. "We know they work and they're good for some people, but we just can't see any kind of population-level impact".

A customer puffs on an e-cigarette at the Henley Vaporium in New York City. Prior to e-cigs, the rate of smoking cessation among the entire population did not change significantly, despite the advocacy of pharmacotherapy.

Related news